يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"mucosa inflammation"', وقت الاستعلام: 2.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

    المصدر: Annals of Oncology

    مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies

  3. 3
    دورية أكاديمية

    المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Centre de malformations vasculaires congénitales

    المصدر: The Lancet Oncology, Vol. 13, no. 2, p. 145-153 (2012)

    العلاقة: boreal:124330; http://hdl.handle.net/2078.1/124330Test; info:pmid/22261362; urn:ISSN:1470-2045; urn:EISSN:1474-5488

  4. 4
    دورية أكاديمية
  5. 5

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Veterinerlik Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Kurt, Ender, Çubukçu, Erdem, Ölmez, Ömer Fatih, Kurt, Meral, Avcı, Nilüfer, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAA-3961-2020

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Cancer

    العلاقة: Danson, S., Middleton, M. R., O'Byrne, Kenneth J., Clemons, M., Ranson, M., Hassan, J., Anderson, H., Burt, P. A., Fairve-Finn, C., Stout, R., Dowd, I., Ashcroft, L., Beresford, C., & Thatcher, N. (2003) Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Cancer, 98(3), pp. 542-553.; https://eprints.qut.edu.au/64965Test/; Faculty of Health; Institute of Health and Biomedical Innovation

  8. 8

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

    المصدر: Annals of Oncology

    مصطلحات موضوعية: Drug dose regimen, Oncology, Survival rate, medicine.medical_treatment, Ovarian Neoplasms/*drug therapy, Carboplatin, Phase 3 clinical trial, Antineoplastic Combined Chemotherapy Protocols, Cytoreductive surgery, Drug fatality, Prospective Studies, Treatment outcome, Disease free survival, Ovarian Neoplasms, Multicenter study, Clinical trial, Heart ventricle arrhythmia, Antineoplastic agent, Paclitaxel, Randomized controlled trial, Granulocyte colony stimulating factor, Infection, Cimetidine, Human, medicine.medical_specialty, Febrile neutropenia, Major clinical study, Article, Disease-Free Survival, Drug Administration Schedule, Ovarian cancer, Paclitaxel/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse, Humans, Aged, Cisplatin, Recombinant granulocyte colony stimulating factor, Minimal residual disease, Leukopenia, Myalgia, Pneumonia, medicine.disease, Survival Analysis, Cardiotoxicity, Regimen, chemistry, Dimetindene, Survival, Alternating cisplatin with carboplatin, Cancer staging, Promethazine, Ovarian neoplasms, Dexamethasone, chemistry.chemical_compound, Controlled clinical trial, Nausea and vomiting, Nephrotoxicity, Fatigue, Priority journal, Drug tolerability, Area under the curve, Gastrointestinal toxicity, Initial treatment, Anemia, Hematology, Arthralgia, Ondansetron, Statistical significance, Chemotherapy regimen, Female, effects/*therapeutic use, Drug hypersensitivity, medicine.drug, Adult, Neutropenia, Fever, Ovary cancer, Liver toxicity, Pain, Mucosa inflammation, Advanced cancer, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Prospective study, Drug administration, business.industry, Carboplatin/administration & dosage, Thrombocytopenia, Standardization, Drug efficacy, Cancer patient, Patient Compliance, Ovary tumor, business, Controlled study, Cisplatin/administration & dosage

  9. 9

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Medikal Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Manavoğlu, Osman, Demiray, Mutlu, Kurt, Ender, Gönüllü, Güzin, Kıyıcı, Murat, Arslan, Murat, AAJ-1027-2021, M-8060-2019

    المصدر: Tumori. 89(4)

  10. 10

    المصدر: Haematologia. 32(1)